Joachim R Kalden

Joachim R Kalden

UNVERIFIED PROFILE

Are you Joachim R Kalden?   Register this Author

Register author
Joachim R Kalden

Joachim R Kalden

Publications by authors named "Joachim R Kalden"

Are you Joachim R Kalden?   Register this Author

100Publications

1161Reads

40Profile Views

Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment.

Nat Rev Rheumatol 2017 Nov;13(12):707-718

Ludwig-Maximilians-University, Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Pettenkoferstraße 8a, D-80336 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2017.187DOI Listing
November 2017

Induction of proliferation and pro-inflammatory cytokine production in rheumatoid arthritis peripheral blood mononuclear cells by a 65 KDa chondrocyte membrane-specific, constitutive target autoantigen (CH65).

Int J Rheum Dis 2017 Sep 16;20(9):1132-1141. Epub 2013 Oct 16.

Department of Medicine III, Institute for Clinical Immunology and Rheumatology, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1756-185X.12167DOI Listing
September 2017

Advances in targeted therapy.

Rheumatology (Oxford) 2016 12;55(suppl 2):ii1-ii2

Rheumatology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew354DOI Listing
December 2016

Emerging Therapies for Rheumatoid Arthritis.

Authors:
Joachim R Kalden

Rheumatol Ther 2016 Jun 3;3(1):31-42. Epub 2016 Jun 3.

Division of Molecular Immunology, Nikolaus-Fiebiger-Center, Friedrich-Alexander University Erlangen-Nürnberg, Glückstraße 6, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40744-016-0032-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999582PMC
June 2016

Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.

Int J Oncol 2012 May 18;40(5):1581-9. Epub 2012 Jan 18.

Division of Gastroenterology, University Hospital of the Phillips-University Marburg, Baldingerstrasse, 35043 Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2012.1337DOI Listing
May 2012

Anti-TNF therapy: what have we learned in 12 years?

Authors:
Joachim R Kalden

Arthritis Res Ther 2011 May 25;13 Suppl 1:S1. Epub 2011 May 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1478-6354-13-S1-S1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123962PMC
May 2011

Advances in rheumatology: new targeted therapeutics.

Arthritis Res Ther 2011 May 25;13 Suppl 1:S5. Epub 2011 May 25.

Department of Medicine, Division of Clinical Immunology and Rheumatology F4-105, Academic Medical Center/University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1478-6354-13-S1-S5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123966PMC
May 2011

Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus.

Arthritis Rheum 2009 Jun;60(6):1733-42

University Hospital of Erlangen, Department of Radiation Oncology, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.24535
Publisher Site
http://dx.doi.org/10.1002/art.24535DOI Listing
June 2009

Inhibition of TNF-alpha reduces transplant arteriosclerosis in a murine aortic transplant model.

Transpl Int 2009 Mar 3;22(3):342-9. Epub 2008 Dec 3.

Department for Internal Medicine 3 and Institute for Clinical Immunology, University Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1432-2277.2008.00802.x
Publisher Site
http://dx.doi.org/10.1111/j.1432-2277.2008.00802.xDOI Listing
March 2009

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.

J Exp Med 2008 Dec 8;205(13):3007-18. Epub 2008 Dec 8.

Interdisciplinary Center of Clinical Research (IZKF), Research Group N2, Nikolaus Fiebiger Center of Molecular Medicine, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20081165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605236PMC
December 2008

The role of high-mobility group box 1 protein in the pathogenesis of autoimmune diseases.

Curr Rheumatol Rep 2008 Oct;10(5):341-2

IZKF Research Group 2, Nikolaus-Fiebiger-Center, Glückstrasse 6, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
October 2008

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.

Nat Med 2008 Jul 8;14(7):748-55. Epub 2008 Jun 8.

Interdisciplinary Center for Clinical Research, research group N2, Nikolaus Fiebiger-Center of Molecular Medicine, University Hospital Erlangen, Glückstrasse 6, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm1763DOI Listing
July 2008

Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.

Thromb Haemost 2008 Jul;100(1):151-3

Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Loschgestrasse 8, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH08-02-0089DOI Listing
July 2008

Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis.

Arthritis Res Ther 2007 ;9(5):R94

Institute for Clinical Microbiology, Immunology and Hygiene, University of Erlangen-Nuremberg, Wasserturmstrasse 3-5, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://arthritis-research.biomedcentral.com/articles/10.1186
Publisher Site
http://dx.doi.org/10.1186/ar2294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212580PMC
April 2008

Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.

Int Immunol 2008 Apr 28;20(4):601-13. Epub 2008 Feb 28.

Department of Medicine III, Institute for Clinical Immunology and Rheumatology, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/dxn019DOI Listing
April 2008

Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.

Arthritis Rheum 2008 Apr;58(4):976-84

Laboratory of Experimental Rheumatology and Neuroendocrino-Immunology, Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.23385DOI Listing
April 2008

Hypothesis: human serum-borne albumin bound lipids promote cellular survival after apoptosis induction by a variety of stimuli.

Apoptosis 2008 Feb;13(2):319-28

Department of Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10495-007-0168-3DOI Listing
February 2008

High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.

Isr Med Assoc J 2008 Jan;10(1):26-8

IZKF research group 2, Nikolaus-Fiebiger-Center of Molecular Medicine, University Hospital Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
January 2008

Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.

J Immunol 2007 Sep;179(6):3613-21

Department of Medicine V, Division of Rheumatology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.179.6.3613DOI Listing
September 2007

Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases.

Authors:
Joachim R Kalden

Arthritis Res 2002 24;4 Suppl 2:S34-40. Epub 2002 May 24.

Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nurnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238220PMC
http://dx.doi.org/10.1186/ar552DOI Listing
August 2007

The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritis.

Mod Rheumatol 2005 ;15(1):9-18

Institute for Clinical Immunology, Department of Medicine III, Friedrich-Alexander University of Erlangen-Nuremberg, Glückstrasse 4a, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10165-004-0366-6DOI Listing
June 2007

Removal of dying cells and systemic lupus erythematosus.

Mod Rheumatol 2005 ;15(6):383-90

Institute for Clinical Immunology, Department of Medicine 3, Friedrich-Alexander University of Erlangen-Nuremberg, Glückstrasse 4a, 91054, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10165-005-0430-xDOI Listing
June 2007

Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells.

Immunology 2006 Sep 6;119(1):43-53. Epub 2006 Jun 6.

Department of Medicine III, Institute for Clinical Immunology and Rheumatology, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2567.2006.02404.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1782327PMC
September 2006

IFNGR1 single nucleotide polymorphisms in rheumatoid arthritis.

Arthritis Res Ther 2006 23;8(3):R63. Epub 2006 Mar 23.

Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, University of Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar1927DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526613PMC
August 2006

Apoptosis and autoimmunity: when apoptotic cells break their silence.

Curr Rheumatol Rep 2006 Aug;8(4):245-7

Department of Internal Medicine III, Friedrich-Alexander University of Erlangen-Nuremberg, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
August 2006

Palifermin as treatment in dose-intense conventional polychemotherapy induced mucositis.

Haematologica 2006 Aug;91(8 Suppl):ECR32

Department of Internal Medicine III University of Erlangen - Nuremberg, Germany.

View Article

Download full-text PDF

Source
August 2006

Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis.

Arthritis Rheum 2006 May;54(5):1491-500

Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, University of Erlangen-Nuremberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21832DOI Listing
May 2006

Lectins detect changes of the glycosylation status of plasma membrane constituents during late apoptosis.

Cytometry A 2006 Apr;69(4):230-9

Department of Medicine III, Institute for Clinical Immunology, Friedrich-Alexander University Erlangen-Nuremberg, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cyto.a.20206
Publisher Site
http://dx.doi.org/10.1002/cyto.a.20206DOI Listing
April 2006

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.

Autoimmun Rev 2006 Apr 27;5(4):269-72. Epub 2005 Oct 27.

Department of Internal Medicine III and Institute for Clinical Rheumatology and Immunology, University of Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S1568997205001758/1-s2.0-S156899720500
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S156899720500175
Publisher Site
http://dx.doi.org/10.1016/j.autrev.2005.10.001DOI Listing
April 2006

CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas.

Immunol Cell Biol 2006 Feb;84(1):51-8

Department of Medicine III and Institute for Clinical Immunology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1711.2005.01402.xDOI Listing
February 2006

The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells.

Eur J Immunol 2005 Dec;35(12):3631-42

Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200535029DOI Listing
December 2005

Inhibition of sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytes.

Biochem Pharmacol 2005 Dec 2;71(1-2):126-35. Epub 2005 Nov 2.

Department of Internal Medicine V, Division of Rheumatology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2005.10.004DOI Listing
December 2005

Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.

J Rheumatol 2005 Dec;32(12):2291-8

Institute for Clinical Microbiology, Immunology and Hygiene, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
December 2005

The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.

J Immunol 2005 Nov;175(9):6107-16

Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.175.9.6107DOI Listing
November 2005

Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases.

Arthritis Rheum 2005 Nov;52(11):3337-48

Institute for Clinical Immunology and Rheumatology, Dept. of Internal Medicine III, University of Erlangen-Nuremberg, Krankenhausstrasse 12, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.21350
Publisher Site
http://dx.doi.org/10.1002/art.21350DOI Listing
November 2005

Multiple bone lesions of systemic multifocal fibrosclerosis.

AJR Am J Roentgenol 2005 Sep;185(3):668-70

Department of Internal Medicine V, Division of Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.185.3.01850668DOI Listing
September 2005

Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis.

J Rheumatol 2005 Aug;32(8):1620-31

Medizinische Klinik III, Institute for Clinical Immunology, Erlangen, Germany.

View Article

Download full-text PDF

Source
August 2005

The evolution of human anti-double-stranded DNA autoantibodies.

Proc Natl Acad Sci U S A 2005 Jun 20;102(26):9258-63. Epub 2005 Jun 20.

Hematopoiesis Unit, Department of Biology, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander University Erlangen-Nuremberg, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0500132102
Publisher Site
http://dx.doi.org/10.1073/pnas.0500132102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1166593PMC
June 2005

Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis?

Ann N Y Acad Sci 2005 Jun;1051:799-810

Department of Internal Medicine III, Friedrich-Alexander University of Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1196/annals.1361.123
Publisher Site
http://dx.doi.org/10.1196/annals.1361.123DOI Listing
June 2005

Impaired clearance of dying cells in systemic lupus erythematosus.

Autoimmun Rev 2005 Apr 8;4(4):189-94. Epub 2004 Dec 8.

Institute for Clinical Immunology, Friedrich-Alexander-University of Erlangen-Nuremberg, Glückstrasse 4a, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S156899720400221
Publisher Site
http://dx.doi.org/10.1016/j.autrev.2004.10.007DOI Listing
April 2005

Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.

Arthritis Rheum 2005 Feb;52(2):451-60

Nikolaus Fiebiger Center for Molecular Medicine and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.20863DOI Listing
February 2005

Loss of GM1 surface expression precedes annexin V-phycoerythrin binding of neutrophils undergoing spontaneous apoptosis during in vitro aging.

Cytometry A 2004 Dec;62(2):75-80

Institute for Clinical Immunology, Department of Medicine III, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cyto.a.20090
Publisher Site
http://dx.doi.org/10.1002/cyto.a.20090DOI Listing
December 2004

Defects in the disposal of dying cells lead to autoimmunity.

Curr Rheumatol Rep 2004 Dec;6(6):401-7

Institute for Clinical Immunology, Friedrich-Alexander-University of Erlangen-Nuremberg, Glückstrasse 4a, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
December 2004

Detection and specification of noncomplement binding anti-HLA alloantibodies.

Hum Immunol 2004 Nov;65(11):1288-96

Institute for Clinical Immunology and Department of Medicine, University of Erlangen-Nuremberg, Erlangen-Nuremberg, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S019888590400605
Publisher Site
http://dx.doi.org/10.1016/j.humimm.2004.08.182DOI Listing
November 2004

Dysregulation of apoptosis as mechanism supporting the induction of autoimmunity.

Curr Rheumatol Rep 2004 Aug;6(4):249-51

Department of Medicine V, Division of Rheumatology, University of Heidelberg, Hospitalstrasse 3, 69115 Heidelberg, Germany.

View Article

Download full-text PDF

Source
August 2004

Apoptosis and systemic lupus erythematosus.

Rheum Dis Clin North Am 2004 Aug;30(3):505-27, viii-ix

Institute for Clinical Immunology and Rheumatology, Medical Department III, University of Erlangen-Nüremberg, Glueckstrasse 4a, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2004.04.006DOI Listing
August 2004

The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.

J Rheumatol Suppl 2004 Jun;71:13-20

Division of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
June 2004

Leflunomide: a manageable safety profile.

J Rheumatol Suppl 2004 Jun;71:21-4

Department of Rheumatology, University Medical Centre Nijmegen, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
June 2004

Lefunomide in combination therapy.

J Rheumatol Suppl 2004 Jun;71:25-30

Department of Internal Medicine III, Universitaet Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
June 2004

Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II.

J Exp Med 2004 May 26;199(9):1285-91. Epub 2004 Apr 26.

Department of Medicine III, Institute for Clinical Immunology and Rheumatology, University of Erlangen-Nuremberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20032158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211900PMC
May 2004

Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10.

J Immunol 2004 May;172(10):6427-34

Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.172.10.6427DOI Listing
May 2004

Clinical images: Periarticular inflammation in rapidly developing Jaccoud's arthropathy.

Arthritis Rheum 2004 May;50(5):1700

University of Erlangen, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.20262DOI Listing
May 2004

GATA-3 in human T cell helper type 2 development.

J Exp Med 2004 Feb;199(3):423-8

Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, University of Erlangen-Nuremberg, 91054, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20031323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211796PMC
February 2004

Accumulation of histones in cell lysates precedes expression of apoptosis-related phagocytosis signals in human lymphoblasts.

Ann N Y Acad Sci 2003 Dec;1010:221-4

Department of Medicine III, Institute for Clinical Immunology, Krankenhausstrasse 12, University of Erlangen-Nuremberg, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1299.039DOI Listing
December 2003

Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells.

J Immunol 2003 Nov;171(10):5124-9

Department of Internal Medicine III, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.171.10.5124DOI Listing
November 2003

Early detection of apoptosis by staining of acid-treated apoptotic cells with FITC-labeled lectin from Narcissus pseudonarcissus.

Cytometry A 2003 Oct;55(2):86-93

Institute for Clinical Immunology and Rheumatology, University of Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.a.10078DOI Listing
October 2003

The putative role of apoptosis-modified histones for the induction of autoimmunity in Systemic Lupus Erythematosus.

Biochem Pharmacol 2003 Oct;66(8):1441-6

Department of Medicine III, Institute for Clinical Immunology and Rheumatology, University of Erlangen-Nuremberg, Krankenhausstr. 12, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0006-2952(03)00495-7DOI Listing
October 2003

UV or X-irradiation increases the cytoplasmic accumulation of rhodamine 123 in various cancer cell lines.

Strahlenther Onkol 2003 Aug;179(8):564-70

Institute for Clinical Immunology, Department of Medicine III, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
August 2003

Impaired clearance of apoptotic cells in systemic lupus erythematosus: challenge of T and B cell tolerance.

Curr Rheumatol Rep 2003 Jun;5(3):175-7

Institute for Clinical Immunology and Rheumatology, Department of Internal Medicine III, Friedrich-Alexander University Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
June 2003

Perspectives for TNF-alpha-targeting therapies.

Arthritis Res 2002 9;4 Suppl 3:S17-24. Epub 2002 May 9.

Institute for Clinical Immunology and Rheumatology, Department of Medicine, University of Erlangen-Nuremberg, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240140PMC
http://dx.doi.org/10.1186/ar564DOI Listing
May 2003

A fast, simple and sensitive method for the detection and quantification of detergent-resistant membranes.

J Immunol Methods 2002 Dec;271(1-2):25-35

Institute for Clinical Immunology and Rheumatology, University of Erlangen-Nuremberg, Glueckstrasse 4A, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-1759(02)00335-6DOI Listing
December 2002

Expanding role of biologic agents in rheumatoid arthritis.

Authors:
Joachim R Kalden

J Rheumatol Suppl 2002 Nov;66:27-37

Department of Internal Medicine III, Institute for Clinical Immunology, Erlangen, Germany.

View Article

Download full-text PDF

Source
November 2002

Characterization of monocyte-derived dendritic cells in recent-onset diabetes mellitus type 1.

Clin Immunol 2002 Oct;105(1):17-24

Institute for Clinical Immunology, Department of Medicine III, University of Erlangen-Nuremberg, Krankenhausstrasse 12, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
October 2002

Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation.

J Immunol 2002 Sep;169(6):3392-9

Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.169.6.3392DOI Listing
September 2002

MEK inhibitor U0126 interferes with immunofluorescence analysis of apoptotic cell death.

Cytometry 2002 Aug;48(4):179-84

Institute for Clinical Immunology, Department of Medicine III, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.10127DOI Listing
August 2002

The expanding world of autoimmunity.

Trends Immunol 2002 Jun;23(6):278-9

Dept of Medicine 'B' and Center of Autoimmune Diseases, Sheba Medical Center, 52621, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
June 2002

A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.

J Rheumatol 2002 Jan;29(1):68-74

Autoantibody Standardization Committee in Rheumatic and Related Disorders of the International Union of Immunological Societies, The World Health Organization, The Arthritis Foundation, and Centers for Disease Control and Prevention.

View Article

Download full-text PDF

Source
January 2002